INR 333.7
(0.45%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 412.42 Million INR | -18.85% |
2022 | 508.24 Million INR | 27.46% |
2021 | 398.74 Million INR | 45.18% |
2020 | 274.64 Million INR | 6.78% |
2019 | 257.21 Million INR | 5.87% |
2018 | 242.94 Million INR | 31.45% |
2017 | 184.82 Million INR | -31.41% |
2016 | 269.46 Million INR | 13.45% |
2015 | 237.51 Million INR | 52.03% |
2014 | 156.23 Million INR | 21.59% |
2013 | 128.48 Million INR | 29.11% |
2012 | 99.52 Million INR | -64.91% |
2011 | 283.58 Million INR | 86.89% |
2010 | 151.73 Million INR | 7.59% |
2009 | 141.03 Million INR | -16.56% |
2008 | 169.03 Million INR | 11.23% |
2007 | 151.96 Million INR | 144.57% |
2006 | 62.13 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 105.52 Million INR | -0.58% |
2023 FY | 412.42 Million INR | -18.85% |
2023 Q2 | 131.93 Million INR | -6.8% |
2023 Q1 | 141.56 Million INR | -3.25% |
2023 Q3 | 133.4 Million INR | 1.11% |
2023 Q4 | 106.13 Million INR | -20.44% |
2022 FY | 508.24 Million INR | 27.46% |
2022 Q2 | 122.28 Million INR | 14.36% |
2022 Q3 | 132.71 Million INR | 8.53% |
2022 Q4 | 146.32 Million INR | 10.26% |
2022 Q1 | 106.92 Million INR | -4.39% |
2021 Q1 | 81.72 Million INR | 0.34% |
2021 Q2 | 76.49 Million INR | -6.39% |
2021 Q3 | 128.69 Million INR | 68.23% |
2021 Q4 | 111.83 Million INR | -13.1% |
2021 FY | 398.74 Million INR | 45.18% |
2020 Q3 | 76.71 Million INR | 8.31% |
2020 FY | 274.64 Million INR | 6.78% |
2020 Q2 | 70.82 Million INR | 55.11% |
2020 Q1 | 45.66 Million INR | -42.74% |
2020 Q4 | 81.44 Million INR | 6.16% |
2019 Q3 | 58.78 Million INR | -12.38% |
2019 Q2 | 67.08 Million INR | 30.0% |
2019 Q1 | 51.6 Million INR | 184.14% |
2019 Q4 | 79.74 Million INR | 35.66% |
2019 FY | 257.21 Million INR | 5.87% |
2018 Q3 | 79 Million INR | 24.36% |
2018 FY | 242.94 Million INR | 31.45% |
2018 Q4 | 18.16 Million INR | -77.01% |
2018 Q2 | 63.52 Million INR | -22.77% |
2018 Q1 | 82.25 Million INR | 0.0% |
2017 FY | 184.82 Million INR | -31.41% |
2016 FY | 269.46 Million INR | 13.45% |
2015 FY | 237.51 Million INR | 52.03% |
2014 Q3 | 29.1 Million INR | -17.78% |
2014 Q2 | 35.39 Million INR | 35.91% |
2014 Q1 | 26.04 Million INR | -40.85% |
2014 Q4 | 33.79 Million INR | 16.1% |
2014 FY | 156.23 Million INR | 21.59% |
2013 Q3 | 11.03 Million INR | -9.27% |
2013 Q2 | 12.16 Million INR | 1397.91% |
2013 Q1 | 811.99 Thousand INR | -98.92% |
2013 Q4 | 44.03 Million INR | 299.04% |
2013 FY | 128.48 Million INR | 29.11% |
2012 Q3 | 10.01 Million INR | -4.99% |
2012 Q2 | 10.53 Million INR | 388.98% |
2012 FY | 99.52 Million INR | -64.91% |
2012 Q1 | -3.64 Million INR | 0.0% |
2012 Q4 | 74.99 Million INR | 648.94% |
2011 FY | 283.58 Million INR | 86.89% |
2010 FY | 151.73 Million INR | 7.59% |
2009 FY | 141.03 Million INR | -16.56% |
2008 FY | 169.03 Million INR | 11.23% |
2007 FY | 151.96 Million INR | 144.57% |
2006 FY | 62.13 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 97.401% |
Hester Biosciences Limited | 908.84 Million INR | 54.621% |
Aarti Drugs Limited | 1.16 Billion INR | 64.674% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 86.585% |
Albert David Limited | 1.02 Billion INR | 59.808% |
Alembic Limited | 872.45 Million INR | 52.728% |
Alkem Laboratories Limited | 32.83 Billion INR | 98.744% |
Bafna Pharmaceuticals Limited | 455.58 Million INR | 9.473% |
Bajaj HealthCare Limited | 985.34 Million INR | 58.144% |
Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -5947.317% |
Brooks Laboratories Limited | 51.18 Million INR | -705.836% |
Eris Lifesciences Limited | 4.94 Billion INR | 91.656% |
FDC Limited | 3.49 Billion INR | 88.216% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 96.457% |
Gufic Biosciences Limited | 1.18 Billion INR | 65.243% |
Hikal Limited | 4.46 Billion INR | 90.761% |
Ind-Swift Limited | 946.56 Million INR | 56.429% |
Innova Captab Limited | 931.03 Million INR | 55.702% |
IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | 81.262% |
Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | 5.957% |
Jubilant Pharmova Limited | 14.45 Billion INR | 97.147% |
Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 61.606% |
Lupin Limited | 125.09 Billion INR | 99.67% |
Mangalam Drugs & Organics Limited | 162.22 Million INR | -154.227% |
Medico Remedies Limited | 59.67 Million INR | -591.122% |
Morepen Laboratories Limited | 1.98 Billion INR | 79.248% |
Nectar Lifesciences Limited | 932.7 Million INR | 55.781% |
Orchid Pharma Limited | 800.77 Million INR | 48.496% |
Procter & Gamble Health Limited | 2.99 Billion INR | 86.231% |
RPG Life Sciences Limited | 1.63 Billion INR | 74.783% |
Sigachi Industries Limited | 579.88 Million INR | 28.878% |
Solara Active Pharma Sciences Limited | 2.55 Billion INR | 83.852% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 70.599% |
Themis Medicare Limited | 1.12 Billion INR | 63.366% |
Unichem Laboratories Limited | 6.72 Billion INR | 93.868% |
Vaishali Pharma Limited | 84.02 Million INR | -390.815% |
Wanbury Limited | 978.96 Million INR | 57.871% |
Windlas Biotech Limited | 1 Billion INR | 59.024% |
ZIM Laboratories Limited | 1.01 Billion INR | 59.289% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 80.584% |
Ipca Laboratories Limited | 18.98 Billion INR | 97.828% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.733% |
Venus Remedies Limited | 1.91 Billion INR | 78.478% |
Sakar Healthcare Limited | 204.07 Million INR | -102.092% |
Aurobindo Pharma Limited | 55.65 Billion INR | 99.259% |
Divi's Laboratories Limited | 14.17 Billion INR | 97.089% |
AstraZeneca Pharma India Limited | 2.47 Billion INR | 83.326% |
Mankind Pharma Limited | 29.27 Billion INR | 98.591% |
Sequent Scientific Limited | 2.9 Billion INR | 85.787% |
Laurus Labs Limited | 11.9 Billion INR | 96.537% |
Neuland Laboratories Limited | 2.92 Billion INR | 85.923% |
J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 97.212% |
Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 99.122% |
Zydus Lifesciences Limited | 125.21 Billion INR | 99.671% |
Amrutanjan Health Care Limited | 2.09 Billion INR | 80.305% |
Wockhardt Limited | 8.48 Billion INR | 95.136% |
Bal Pharma Limited | 555.62 Million INR | 25.773% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 99.57% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 70.94% |
Par Drugs and Chemicals Limited | 58.28 Million INR | -607.567% |
Caplin Point Laboratories Limited | 2.17 Billion INR | 81.033% |
Shilpa Medicare Limited | 3.33 Billion INR | 87.63% |
Valiant Laboratories Limited | 138.02 Million INR | -198.797% |
Ajanta Pharma Limited | 30.46 Billion INR | 98.646% |
Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -2801.759% |
Granules India Limited | 10.31 Billion INR | 96.001% |
Medicamen Biotech Limited | 335.16 Million INR | -23.051% |
Syncom Formulations (India) Limited | 345.63 Million INR | -19.325% |
Piramal Enterprises Limited | 63.65 Billion INR | 99.352% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 98.075% |
NATCO Pharma Limited | 10.05 Billion INR | 95.9% |
Suven Life Sciences Limited | 109.75 Million INR | -275.788% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -793.55% |
Strides Pharma Science Limited | 9.16 Billion INR | 95.499% |
Indoco Remedies Limited | 12.06 Billion INR | 96.581% |
Alpa Laboratories Limited | 127.38 Million INR | -223.777% |
Lasa Supergenerics Limited | 291.17 Million INR | -41.643% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 86.596% |